메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène

SHANGHAI, Oct. 21, 2025 -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced the completion of its acquisition of Foltène, a dermatological hair care brand from Italy. Founded in Milan in 1944 by pharmaceutical researchers, Foltène is renowned for its scientific heritage and pioneering innovation. The brand developed two proprietary active complexes, Tricosaccaride® and Tricalgoxyl®, which are clinically proven to promote thicker, fuller, and healthier-looking hair. Foltène's core product portfolio
- 김갑성 기자
- 2025-10-21 22:00
GROWNSY Joins Babylist Beverly Hills Showroom to Bring Smarter Parenting Solutions to Families

LOS ANGELES, Oct. 21, 2025 -- GROWNSY, a fast-growing baby care brand trusted by parents across the U.S. and beyond, successfully launched in-store at the Babylist Beverly Hills Showroom this past September. A Shared Vision for Modern Families GROWNSY and Babylist share a common goal: to make parenting smarter, simpler, and more joyful. Babylist provides parents with a trusted platform to discover products and build personalized registries, while GROWNSY delivers solutions designed to ease everyday challenges. "With Babylist reaching millions of expecting par
- 김갑성 기자
- 2025-10-21 21:00
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101

TAIPEI and SHANGHAI and SAN FRANCISCO, Oct. 21, 2025 -- HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark Office (USPTO). Titled "ENGINEERED SIRPα VARIANTS AND METHODS OF USE THEREOF", the patent represents major international recognition for the company's innovative technology for immuno-oncology. Mechanism of Action and Novelty of HCB101: An Innovative Fusion Protein Design Developed using HanchorBio's proprietary FBDB
- 김갑성 기자
- 2025-10-21 19:00
HKSH Medical Group to Host Hong Kong's First Asia-Oceania Particle Therapy Co-operative Group Conference

[ 메디채널 김갑성 기자 ] Best Practice by World-class Experts in Proton Therapy Transforming Precision Cancer Management HONG KONG, Oct. 21, 2025 -- HKSH Medical Group (HKSH) introduced Hong Kong's only and the Greater Bay Area's first proton therapy system in 2023, after two decades of planning and preparation. Now that the HKSH Proton Therapy Centre has been in operation for two years, following the "Proton Therapy Joint Training Course" co-organised with the National Cancer Center in Beijing this June and the initiation of the ten-month "HKSH Cancer Centre Proton Therapy Tra
- 김갑성 기자
- 2025-10-21 16:02
Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

GOTHENBURG, Sweden, Oct. 21, 2025 -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's net sales increased organically by 9,5% while order intake rose by 4,7% organically. Acute Care Therapies continued to meet the higher demand for ventilators, in the wake of an ongoing market consolidation. Order intake and sales of ECLS consumables were also significant. Both Life Science and
- 김갑성 기자
- 2025-10-21 14:45
Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention

KUALA LUMPUR, Malaysia, Oct. 21, 2025 -- Abbott, a global healthcare leader, and BIG CARiNG Group (BCG), one of Malaysia's largest retail pharmacies, announced a strategic three-year collaboration to promote influenza awareness across Malaysia. The Influenza Awareness Program, running from 2025 to 2027, is designed to elevate public understanding of influenza and encourage proactive health management. This nationwide initiative reflects a shared commitment to improving community health outcomes through education, engagement, and accessible healthcare information. Through a phased rollo
- 김갑성 기자
- 2025-10-21 13:12
Biomom Partners with Kolmar BNH to Enhance "Biomom Snow" -- Upgrading Both Quality and Taste

SEOUL, South Korea, Oct. 21, 2025 -- Health supplement brand Biomom has renewed its flagship children's probiotic, "Biomom Snow," with enhanced quality and improved flavor. As part of the renewal, Biomom selected Kolmar BNH Co., Ltd. as its new manufacturing partner, reinforcing its commitment to consumer satisfaction and product innovation Biomom Snow contains 10 billion CFU probiotics per stick, using 19 strains certified by the Korean Ministry of Food and Drug Safety (MFDS). It also includes essential nutrients such as Vitamin B complex, Vitamin D, folic acid
- 김갑성 기자
- 2025-10-21 11:00
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy

TAIPEI and SAN DIEGO, Oct. 21, 2025 -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system. DeepMind reported that its latest AI model successfully generated and experimentally validated a new hypothesis for cancer treatment, calling it "a milestone for AI in science." Through large-scale analysis of tumor cell data and more than 4,000 potential drug candidates, DeepMind's model
- 김갑성 기자
- 2025-10-21 10:49
Zero Formalin Specimen Preservation Solution for Formalin-Free Classrooms

BANGKOK, Oct. 21, 2025 -- Anatomy instructors at the Faculty of Veterinary Science, Chulalongkorn University, have developed Zero Formalin (ZF)—a formalin-free animal specimen preservation solution—to create safer classrooms and reduce health risks for students and staff. The solution is now used for all animal bodies in anatomy classes. In order to become veterinarians, students at the Faculty of Veterinary Science must spend a long period studying anatomy. They examine animal cadavers that have been preserved using formalin—a clear, highly toxic chemical with a strong, punge
- 김갑성 기자
- 2025-10-21 10:00
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

[ 메디채널 김갑성 기자 ] SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 21, 2025 -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and commercialization of treatments for disorders of the central nervous system (CNS) and oncology worldwide, today announced the establishment of Mentis Care, Inc., a joint venture with a leading Brazil-based pharmaceutical company, Eurofarma, with presence in 24 countries, including North Ameri
- 김갑성 기자
- 2025-10-21 09:20

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-11-04_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 04일 14시 40분